AWAK Attracts Investment Billions
Singapore-based AWAK Technologies’ miniaturized sorbent platform for PD and HD regenerates dialysate to use up to 90% less fluid. This package was intriguing enough to attract an $11.2B investment from Accuron MedTech—improving its changes of reaching the market!
Read the full article » | Posted 06/12/2017
Related Articles
- AWAK PD Attracts Funding Posted 01/09/2020
- PD to Go, Please Posted 12/10/2019
- Portable, Wearable Dialysis—from Russia With Love Posted 12/10/2019
- Fresenius-licensed Endexo Smart Polymer Gets FDA Breakthrough Status to Prevent Clots Posted 11/16/2019
- Diality is Moving Forward with Portable Home HD Posted 11/16/2019